03 July 2012 10:01 [Source: ICIS news]
LONDON (ICIS)--BASF is selling its marine biopolymers business to ?xml:namespace>
BASF said it had signed a contract to transfer the business, Chitosan marine biopolymers, to Seagarden with the transaction expected to be completed by August 2012.
Financial details of the transaction were not disclosed.
Following completion of the transaction, Seagarden will own the Chitosan business including the production site in
Chitosan marine biopolymers are used in personal care products and as pharmaceutical ingredients.
Seagarden is a specialty marine ingredients company selling 100% natural ingredients to the global savoury and nutritional markets.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections